1. Home
  2. CTKB vs YDES Comparison

CTKB vs YDES Comparison

Compare CTKB & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytek Biosciences Inc.

CTKB

Cytek Biosciences Inc.

HOLD

Current Price

$4.54

Market Cap

541.1M

Sector

Health Care

ML Signal

HOLD

YDES

YD Bio Limited Ordinary Shares

HOLD

Current Price

$2.21

Market Cap

543.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTKB
YDES
Founded
1990
2013
Country
United States
Taiwan
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
541.1M
543.0M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
CTKB
YDES
Price
$4.54
$2.21
Analyst Decision
Hold
Analyst Count
4
0
Target Price
$5.63
N/A
AVG Volume (30 Days)
2.1M
344.1K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$193,015,000.00
N/A
Revenue This Year
$5.42
N/A
Revenue Next Year
$7.03
N/A
P/E Ratio
N/A
N/A
Revenue Growth
17.67
N/A
52 Week Low
$3.22
$1.70
52 Week High
$6.18
$25.00

Technical Indicators

Market Signals
Indicator
CTKB
YDES
Relative Strength Index (RSI) 53.51 40.02
Support Level $4.17 $2.14
Resistance Level $4.78 $3.05
Average True Range (ATR) 0.19 0.40
MACD -0.01 0.08
Stochastic Oscillator 42.27 32.59

Price Performance

Historical Comparison
CTKB
YDES

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.

About YDES YD Bio Limited Ordinary Shares

YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.

Share on Social Networks: